Mark L Chiu

8PUBLICATIONS
2CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical molecular engineering of nucleic acids and proteinsBiomaterialsHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 16, 2026
CDCP1-targeted antibody-drug conjugates and immunocytokines for cancer therapy.

|May 07, 2026
A novel insulin-like growth factor II-based masking domain for conditional activation of therapeutic antibodies.

|Mar 24, 2026
Effect of ADCC-enhancing mutations on N-glycan profiles of human IgG1 antibodies.

Lu Han, Hao Jiang, Mark L Chiu

|Nov 20, 2025
Engineering tandem VHHs to target different epitopes to enhance antibody-dependent cell-mediated cytotoxicity.

Yuqiang Xu, Hao Jiang, Limin Chen

|Nov 13, 2025
Targeted Hyaluronan Degradation Enhanced Tumor Growth Inhibition in Gastrointestinal Cancer Models.

Fulai Zhou, Guangmao Mu, Honglei Bi

|Aug 22, 2025
Guidelines in the Preparation of Fully Synthetic, Human Single-Domain Antibody Phage Display Libraries.

Mark A Tornetta, Brian P Whitaker, Olivia M Cantwell

Pageof 2

Frequent Collaborators

2 joint publications

Di Zhang

1 joint publications

Mark A Tornetta